| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Lazarus HM | |
| Auletta JJ | |||
| P2860 | cites work | Antigen presentation and T cell stimulation by dendritic cells | Q22255632 |
| Toll-like receptor signalling | Q24570126 | ||
| IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells | Q24621753 | ||
| Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization | Q24655648 | ||
| Innate immune recognition | Q27860721 | ||
| Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice | Q28204960 | ||
| Interleukin-7: from bench to clinic | Q28217495 | ||
| Cancer and the chemokine network | Q28269751 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Toll-like receptors in innate immunity | Q28297257 | ||
| Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components | Q28511151 | ||
| CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs | Q28594485 | ||
| Toll-like receptor control of the adaptive immune responses | Q29547305 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Interleukin-12 and the regulation of innate resistance and adaptive immunity | Q29614602 | ||
| Visualizing dendritic cell networks in vivo | Q29616233 | ||
| Cellular responses to interferon-gamma | Q29618567 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| The biology of chemokines and their receptors | Q29619170 | ||
| Prevention of graft versus host disease by inactivation of host antigen-presenting cells | Q78016071 | ||
| Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor | Q78409932 | ||
| Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation | Q78744522 | ||
| A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells | Q78863058 | ||
| Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization | Q79267157 | ||
| Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation | Q79333283 | ||
| CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study | Q80064391 | ||
| Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation | Q80388681 | ||
| Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation | Q80388695 | ||
| Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation | Q80884347 | ||
| Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes | Q81042784 | ||
| Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation | Q81073751 | ||
| Adoptive immunotherapy for EBV-associated malignancies | Q81204067 | ||
| FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function | Q81213577 | ||
| Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation | Q74129762 | ||
| Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell | Q74198800 | ||
| Immunological aspects of haploidentical stem cell transplantation in children | Q74218191 | ||
| Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease | Q74389162 | ||
| T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease | Q74412470 | ||
| Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery | Q74418085 | ||
| Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors | Q74422549 | ||
| Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products | Q74484150 | ||
| Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft | Q74502752 | ||
| Enhanced susceptibility to apoptosis in T cells recovering after autologous peripheral blood progenitor cell transplantation: reversal by interleukin-15 | Q74535655 | ||
| T-Cell recovery in adults and children following umbilical cord blood transplantation | Q74549176 | ||
| Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation | Q74570310 | ||
| Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells? | Q74595797 | ||
| Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells | Q74605857 | ||
| NK cells: a lesson from mismatched hematopoietic transplantation | Q74675080 | ||
| Dendritic cell recovery after autologous stem cell transplantation | Q74713909 | ||
| Interleukin 7 worsens graft-versus-host disease | Q74805797 | ||
| Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation | Q74816925 | ||
| Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease | Q76319383 | ||
| FLT3: receptor and ligand. Biology and potential clinical application | Q77163163 | ||
| Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches | Q77478694 | ||
| Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients | Q77601922 | ||
| A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation | Q77601930 | ||
| Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease | Q77678386 | ||
| Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation | Q77810550 | ||
| Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4 | Q77952550 | ||
| Antibodies to 70 kD and 90 kD heat shock proteins are associated with graft-versus-host disease in peripheral blood stem cell transplant recipients | Q77982976 | ||
| Interplay of natural killer cells and their receptors with the adaptive immune response | Q35904393 | ||
| Regulation of hematopoietic stem cell growth | Q35905170 | ||
| The critical role of type-1 innate and acquired immunity in tumor immunotherapy | Q35911850 | ||
| Genomic screening and complications of hematopoietic stem cell transplantation: has the time come? | Q35920868 | ||
| Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair | Q35940370 | ||
| Plasmacytoid dendritic cells in immunity | Q35953140 | ||
| Graft-versus-host disease: how to translate new insights into new therapeutic strategies | Q35966761 | ||
| Mechanisms and functional significance of tumour-induced dendritic-cell defects | Q35968465 | ||
| LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation | Q36028584 | ||
| Expansion and activation of natural killer cells from PBMC for immunotherapy of hepatocellular carcinoma | Q36066259 | ||
| Transplantation of autologous peripheral blood progenitor cells: impact of CD34-cell selection on immunological reconstitution | Q34575606 | ||
| Chemokines: agents for the immunotherapy of cancer? | Q34576416 | ||
| Roles of heat-shock proteins in innate and adaptive immunity | Q34576423 | ||
| Differentiation plasticity of hematopoietic cells | Q34607310 | ||
| Spinning molecular immunology into successful immunotherapy | Q34632056 | ||
| Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing. | Q34669010 | ||
| The role of donor age in naive T-cell recovery following allogeneic hematopoietic stem cell transplantation: the younger the better | Q34769856 | ||
| Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect | Q34802287 | ||
| Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells | Q34843244 | ||
| Distinct dendritic cell subsets differentially regulate the class of immune response in vivo | Q34950113 | ||
| Heat shock protein 70: role in antigen presentation and immune stimulation | Q35049403 | ||
| Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation | Q35060002 | ||
| The whys and hows of hematopoietic progenitor and stem cell mobilization | Q35084569 | ||
| Monoclonal antibodies for the prevention and treatment of graft-versus-host disease | Q35206367 | ||
| Immunogenetics of killer-cell immunoglobulin-like receptors | Q35212392 | ||
| Graft-versus-leukemia reactions in allogeneic chimeras | Q35213001 | ||
| Immune regulation by regulatory T cells: implications for transplantation | Q35216466 | ||
| The Pathophysiology of Acute Graft-versus-Host Disease | Q35578563 | ||
| Immunoregulatory Cells for Transplantation Tolerance and Graft-versus-Leukemia Effect | Q35578569 | ||
| CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells | Q35602700 | ||
| Natural killer lymphocytes: biology, development, and function | Q35611483 | ||
| The role of monoclonal antibodies in stem cell transplantation | Q35670242 | ||
| Antigen-induced regulatory T cells | Q35693709 | ||
| Innate immunity via Toll-like receptors and Nod proteins | Q35702964 | ||
| Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow | Q35721681 | ||
| Immunotherapeutic uses of CpG oligodeoxynucleotides | Q35730784 | ||
| Monoclonal antibodies as therapeutic agents for cancer | Q35761687 | ||
| The pathophysiology of chronic graft-versus-host disease | Q35787489 | ||
| Therapeutics targeting the innate immune system | Q35824051 | ||
| Manipulating dendritic cell biology for the active immunotherapy of cancer | Q35825249 | ||
| Strategies to improve dendritic cell-based immunotherapy against cancer | Q35834353 | ||
| Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? | Q35858408 | ||
| Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays | Q35892098 | ||
| The interface between innate and adaptive immunity | Q35904384 | ||
| Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants | Q29619458 | ||
| Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant | Q31021131 | ||
| A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease | Q32061758 | ||
| Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution | Q33180586 | ||
| CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection. | Q33186135 | ||
| Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma | Q33334822 | ||
| Infections in recipients of blood and marrow transplantation | Q33769714 | ||
| Chemokines and cell migration in secondary lymphoid organs | Q33807114 | ||
| Danger signals: SOS to the immune system | Q33931055 | ||
| Dendritic cells in cancer immunotherapy | Q33932695 | ||
| The immune system. First of two parts | Q33959636 | ||
| The immune system. Second of two parts | Q33966058 | ||
| Evolving strategies to address adverse transplant outcomes associated with T cell depletion | Q33968207 | ||
| Mesenchymal stem cells: biology and potential clinical uses | Q34034011 | ||
| Type 1/Type 2 immunity in infectious diseases | Q34105379 | ||
| Interleukin 15: biology and relevance to human disease | Q34116304 | ||
| On guard--activating NK cell receptors | Q34117069 | ||
| Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation | Q34124707 | ||
| Tolerance and autoimmunity | Q34167913 | ||
| Recognition of tumor cells by the innate immune system | Q34167935 | ||
| Inheritance and drug response | Q34175608 | ||
| Pharmacogenomics--drug disposition, drug targets, and side effects | Q34175616 | ||
| Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. | Q34178128 | ||
| Interleukin-18 regulates both Th1 and Th2 responses | Q34178165 | ||
| Vaccination against infectious disease following hematopoietic stem cell transplantation | Q34219146 | ||
| The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients | Q34244446 | ||
| Developmental pharmacology--drug disposition, action, and therapy in infants and children | Q34247047 | ||
| Genetically haploidentical stem cell transplantation for acute leukemia | Q34255634 | ||
| The instructive role of innate immunity in the acquired immune response | Q34375203 | ||
| Bone marrow stromal damage after chemo/radiotherapy: occurrence, consequences and possibilities of treatment. | Q34430348 | ||
| The biology of human natural killer-cell subsets | Q34430869 | ||
| Deactivation of the innate cellular immune response following endotoxic and surgical injury. | Q34457307 | ||
| Endotoxin tolerance: a review | Q34487880 | ||
| CpG motifs in bacterial DNA and their immune effects | Q34542287 | ||
| Mobilization of long-term reconstituting hematopoietic stem cells in mice by recombinant human interleukin 7 | Q36364325 | ||
| The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor | Q36370212 | ||
| Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis | Q37379687 | ||
| CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses | Q37384050 | ||
| Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. | Q37387081 | ||
| Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis. | Q40477255 | ||
| Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model | Q40522104 | ||
| Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions | Q40535464 | ||
| Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. | Q40565739 | ||
| Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation | Q40600413 | ||
| Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation | Q40618761 | ||
| Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study | Q40627960 | ||
| Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity | Q40628602 | ||
| Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice | Q40681753 | ||
| Heterologous cells cooperate to augment stem cell migration, homing, and engraftment. | Q40695109 | ||
| Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics | Q40782361 | ||
| Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. | Q40851124 | ||
| Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients | Q40898117 | ||
| Immunological reconstitution following bone marrow transplantation | Q41561698 | ||
| Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies | Q43505338 | ||
| Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults | Q43536885 | ||
| Cutting edge: bacterial lipoprotein induces endotoxin-independent tolerance to septic shock | Q43776187 | ||
| Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation | Q43796852 | ||
| Cutting Edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3'-OH kinase pathway. | Q43829914 | ||
| Hematopoietic stem cells from the marrow of mice treated with Flt3 ligand are significantly expanded but exhibit reduced engraftment potential. | Q43974585 | ||
| Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors | Q43974989 | ||
| Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells | Q43999066 | ||
| Interferon-alpha therapy following autologous peripheral blood stem cell transplantation for adult T cell leukemia/lymphoma | Q44020097 | ||
| CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back | Q44117304 | ||
| Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation | Q44189627 | ||
| Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation | Q44213064 | ||
| Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial | Q44248216 | ||
| Immune reconstitution following allogeneic peripheral blood stem cell transplants | Q44306515 | ||
| Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions | Q44391214 | ||
| Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. | Q44432142 | ||
| Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation | Q44451886 | ||
| Toll-like receptors stimulate human neutrophil function | Q44493366 | ||
| Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion | Q44509640 | ||
| T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation | Q44556832 | ||
| Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation | Q44571777 | ||
| Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression | Q44592649 | ||
| Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning | Q44612723 | ||
| LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease | Q44620762 | ||
| Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine | Q44703236 | ||
| Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand | Q44756910 | ||
| Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation | Q45203125 | ||
| NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. | Q47225487 | ||
| Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning | Q47231959 | ||
| Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution | Q47266196 | ||
| Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC. | Q47326564 | ||
| Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation. | Q47589957 | ||
| Immune reconstitution, infectious complications and post transplant supportive care measures after autologous blood and marrow transplantation in children | Q47623120 | ||
| Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation | Q47685290 | ||
| Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help | Q47800822 | ||
| Regulation of interferon-gamma production by IL-12 and IL-18. | Q47933801 | ||
| Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. | Q47977196 | ||
| An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease | Q47995415 | ||
| Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells | Q48000642 | ||
| Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation | Q48007257 | ||
| Ex vivo expansion of natural killer cells for clinical applications | Q48034920 | ||
| CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients. | Q51637388 | ||
| Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cells. | Q51998724 | ||
| A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors. | Q52006361 | ||
| Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele. | Q52007270 | ||
| Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. | Q52018516 | ||
| Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. | Q52044336 | ||
| The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. | Q53875134 | ||
| A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation | Q53927810 | ||
| A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation. | Q53975414 | ||
| Distinct patterns and kinetics of chemokine production regulate dendritic cell function. | Q54093362 | ||
| Chronic graft-versus-host disease | Q56340012 | ||
| Dendritic cells giveth and taketh away | Q56903003 | ||
| Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation | Q56905854 | ||
| Transplantation of anergic histoincompatible bone marrow allografts | Q56906962 | ||
| Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation | Q57252638 | ||
| Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation | Q60285338 | ||
| Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma | Q60976795 | ||
| Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells | Q61053489 | ||
| High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution | Q61053494 | ||
| Blockade of CXCR3 Receptor:Ligand Interactions Reduces Leukocyte Recruitment to the Lung and the Severity of Experimental Idiopathic Pneumonia Syndrome | Q61942137 | ||
| Defective Phagocytosis and Clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation | Q61942141 | ||
| Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner | Q61942737 | ||
| High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group | Q70705675 | ||
| Ex vivo purging of allogeneic marrow with L-Leucyl-L-leucine methyl ester. A phase I study | Q71770378 | ||
| Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy | Q72356532 | ||
| Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases | Q73180485 | ||
| Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning | Q73256320 | ||
| FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease | Q73276603 | ||
| Monocytes from mobilized stem cells inhibit T cell function | Q73292906 | ||
| Mechanisms of immune dysfunction in stem cell transplantation | Q73343715 | ||
| Immune reconstitution after autologous purged bone marrow transplantation in children | Q73495520 | ||
| IFN-gamma-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12 | Q73520600 | ||
| Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy | Q73523478 | ||
| Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation | Q73549835 | ||
| IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation | Q73549850 | ||
| Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation | Q73582357 | ||
| Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody | Q73833684 | ||
| Flt3 ligand (FL) treatment of murine donors does not modify graft-versus-host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality | Q73875493 | ||
| Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation | Q73919404 | ||
| Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer | Q74082709 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 835-857 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Immune restoration following hematopoietic stem cell transplantation: an evolving target | |
| P478 | volume | 35 |
| Q39993836 | A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients. |
| Q33694269 | A role for IL-1 receptor-associated kinase-M in prostaglandin E2-induced immunosuppression post-bone marrow transplantation. |
| Q35202366 | BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation |
| Q34447713 | Biobehavioral influences on cancer progression |
| Q36385509 | Biobehavioral influences on recovery following hematopoietic stem cell transplantation |
| Q36339283 | COX-2 expression is upregulated by DNA hypomethylation after hematopoietic stem cell transplantation. |
| Q42615168 | Clonotypic analysis of T cell reconstitution after haematopoietic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency |
| Q42081995 | Comparison of conditioning regimens for alveolar macrophage reconstitution and innate immune function post bone marrow transplant |
| Q33731422 | Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II-III trial (T-cell depletion trial) |
| Q26830857 | Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control? |
| Q33777096 | Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies |
| Q35575464 | Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid |
| Q36707403 | Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation |
| Q37944472 | Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation? |
| Q28080452 | Haploidentical hematopoietic transplantation without T-cell depletion: current status and future perspectives |
| Q37851354 | IRAK-M regulation and function in host defense and immune homeostasis |
| Q28072627 | Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation |
| Q41613648 | Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood |
| Q42572908 | Impaired pulmonary immunity post-bone marrow transplant |
| Q41432449 | Importance of early absolute lymphocyte count after allogeneic stem cell transplantation: a retrospective study |
| Q33597783 | Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation |
| Q33629475 | Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells |
| Q51348958 | L-index as a novel index to evaluate both the intensity and duration of lymphopenia after allogeneic hematopoietic stem cell transplantation. |
| Q39486182 | Lack of evidence for a reciprocal interaction between bacterial and cytomegalovirus infection in the allogeneic stem cell transplantation setting. |
| Q47136178 | Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation |
| Q80034709 | Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients |
| Q81436465 | Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality |
| Q35991311 | PTEN limits alveolar macrophage function against Pseudomonas aeruginosa after bone marrow transplantation. |
| Q36808062 | Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation. |
| Q92397998 | Prospective validation of the L-index reflecting both the intensity and duration of lymphopenia and its detailed evaluation using a lymphocyte subset analysis after allogeneic hematopoietic stem cell transplantation |
| Q83339301 | Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation |
| Q40497285 | Recovery of mucosal-associated invariant T cells after myeloablative chemotherapy and autologous peripheral blood stem cell transplantation |
| Q34832611 | Relevance of laboratory testing for the diagnosis of primary immunodeficiencies: a review of case-based examples of selected immunodeficiencies |
| Q30397259 | Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) |
| Q84626321 | The combination method using magnetic beads and a magnet helps sustain the number of donor BM cells after intra-BM injection, resulting in rapid hematopoietic recovery |
| Q36546286 | The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients |
| Q37313942 | The immunopathology of thymic GVHD. |
| Q35874039 | The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation. |
| Q35225020 | The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects |
| Q36384707 | The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation |
| Q57640701 | Treatment with Low Doses of Polyclonal Immunoglobulin Improves B Cell Function During Immune Reconstitution in a Murine Model |
Search more.